Dianthus Therapeutics, Inc. (DNTH)
107.83
-3.71
(-3.33%)
USD |
NASDAQ |
Aug 28, 11:56
Dianthus Therapeutics Free Cash Flow : -155.71M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -155.71M |
| March 31, 2026 | -130.48M |
| December 31, 2025 | -129.27M |
| September 30, 2025 | -109.63M |
| June 30, 2025 | -100.36M |
| March 31, 2025 | -90.97M |
| December 31, 2024 | -78.28M |
| September 30, 2024 | -62.67M |
| June 30, 2024 | -51.44M |
| March 31, 2024 | -41.65M |
| December 31, 2023 | -36.97M |
| September 30, 2023 | -33.99M |
| June 30, 2023 | -7.509M |
| March 31, 2023 | -19.74M |
| December 31, 2022 | -29.21M |
| September 30, 2022 | -36.03M |
| June 30, 2022 | -67.65M |
| March 31, 2022 | -63.78M |
| Date | Value |
|---|---|
| December 31, 2021 | -60.80M |
| September 30, 2021 | -59.04M |
| June 30, 2021 | -58.29M |
| March 31, 2021 | -64.42M |
| December 31, 2020 | -64.42M |
| September 30, 2020 | -66.26M |
| June 30, 2020 | -63.85M |
| March 31, 2020 | -60.76M |
| December 31, 2019 | -60.16M |
| September 30, 2019 | -61.36M |
| June 30, 2019 | -62.34M |
| March 31, 2019 | -55.98M |
| December 31, 2018 | -49.56M |
| September 30, 2018 | -41.13M |
| June 30, 2018 | -33.94M |
| March 31, 2018 | -29.63M |
| December 31, 2017 | -24.46M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Legend Biotech Corp. | -264.16M |
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Verastem, Inc. | -171.82M |
| Fortress Biotech, Inc. | 120.28M |
| AbbVie, Inc. | 18.21B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.98M |
| Cash from Investing (Quarterly) | -478.52M |
| Cash from Financing (Quarterly) | 10.38M |
| Free Cash Flow Per Share (Quarterly) | -0.8774 |
| Free Cash Flow to Equity (Quarterly) | -49.08M |
| Free Cash Flow to Firm (Quarterly) | -49.16M |
| Free Cash Flow Yield | -3.09% |